Explore 3 Stock Ideas & Industry Insights Download Free Report

Polarean Imaging Plc

Healthcare GB POLX

NoneGBX
0.00(0%)

Last update at 2026-01-21T16:00:12.780716Z

Day Range

--
LowHigh

52 Week Range

4.8084.20
LowHigh

Fundamentals

  • Previous Close 0.08
  • Market Cap14.03M
  • VolumeNone
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-13.76441M
  • Revenue TTM0.34M
  • Revenue Per Share TTM0.002
  • Gross Profit TTM 0.51M
  • Diluted EPS TTM-0.05

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax -13.90560M -14.01600M -6.53452M -6.10334M -5.45466M
Minority interest - - - - -
Net income -14.14062M -13.71556M -6.55425M -6.19502M -5.64253M
Selling general administrative 8.46M 6.52M 5.05M 6.01M 6.16M
Selling and marketing expenses 3.31M 5.56M 0.92M 0.32M 0.03M
Gross profit 0.35M 0.51M 0.71M 1.38M 1.81M
Reconciled depreciation 1.04M 0.93M 0.88M 0.75M 0.63M
Ebit -13.67057M -14.31645M -6.61556M -6.01217M -5.26679M
Ebitda -12.84359M -13.38208M -5.63051M -5.26467M -4.63980M
Depreciation and amortization 0.83M 0.93M 0.99M 0.75M 0.63M
Non operating income net other - - - - -
Operating income -13.67057M -14.31645M -6.61556M -6.01217M -5.26679M
Other operating expenses 14.70M 15.50M 7.67M 8.31M 7.71M
Interest expense 0.02M 0.02M 0.02M 0.09M 0.00000M
Tax provision 0.00000M 0.00000M 0.00000M 0.00000M 0.00000M
Interest income 0.04M 0.00259M 0.10M 0.00051M 0.00018M
Net interest income 0.01M -0.01851M 0.08M -0.09117M -0.18787M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 0.24M -0.30044M 0.02M 0.09M 0.19M
Total revenue 1.03M 1.19M 1.06M 2.30M 2.44M
Total operating expenses 14.02M 14.82M 7.33M 7.39M 7.07M
Cost of revenue 0.68M 0.68M 0.35M 0.93M 0.63M
Total other income expense net -0.23503M 0.30M 0.08M -0.09117M -0.18787M
Discontinued operations - - - - -
Net income from continuing ops -13.90560M -14.01600M -6.53452M -6.10334M -5.45466M
Net income applicable to common shares - -14.01600M -6.53452M -6.10334M -5.45466M
Preferred stock and other adjustments - - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Total assets 22.54M 34.53M 10.88M 7.04M 9.83M
Intangible assets 1.58M 2.19M 2.81M 3.43M 4.04M
Earning assets - - - - -
Other current assets - 0.97M 0.35M 0.64M 4.23M
Total liab 3.23M 2.79M 2.15M 2.45M 2.04M
Total stockholder equity 19.30M 31.74M 8.73M 4.59M 7.79M
Deferred long term liab - - - - -
Other current liab 1.47M 1.43M 0.00000M 1.16M 1.23M
Common stock 0.10M 0.10M 0.08M 0.06M 0.05M
Capital stock 0.10M 0.10M 0.08M 0.06M 0.05M
Retained earnings -52.76580M -38.86021M -24.84420M -18.30968M -12.21277M
Other liab - 0.46M 0.54M 0.51M 0.39M
Good will - - - - -
Other assets - 0.00554M 0.00554M 0.00554M 0.01M
Cash 16.45M 28.87M 6.28M 1.96M 0.88M
Cash and equivalents - - - - -
Total current liabilities 2.21M 1.97M 1.52M 1.89M 1.65M
Current deferred revenue - - 1.00M - -
Net debt -16.09540M -28.38512M -6.06124M -1.84050M -0.87039M
Short term debt 0.14M 0.13M 0.13M 0.07M 0.00521M
Short long term debt - - - 0.00000M 0.00521M
Short long term debt total 0.36M 0.49M 0.22M 0.12M 0.00521M
Other stockholder equity 71.97M 70.50M 33.50M 22.84M 20.00M
Property plant equipment - 1.06M 0.46M 0.45M 0.02M
Total current assets 19.83M 31.27M 7.61M 3.15M 5.75M
Long term investments - - - - -
Net tangible assets - 29.54M 5.92M 1.16M 3.75M
Short term investments - - - - -
Net receivables 0.11M 0.12M 0.24M 0.55M 4.14M
Long term debt - - - - -
Inventory 1.71M 1.43M 0.98M 0.55M 0.65M
Accounts payable 0.60M 0.41M 0.39M 0.66M 0.42M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - -0.24246M -0.10735M -0.04423M
Additional paid in capital - - - - -
Common stock total equity - - 0.08M 0.06M 0.05M
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 0.44M 0.00554M 0.00554M 0.00554M 0.01M
Deferred long term asset charges - - - - -
Non current assets total 2.71M 3.26M 3.27M 3.89M 4.07M
Capital lease obligations 0.36M 0.49M 0.22M 0.12M -
Long term debt total - - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments -0.06395M -0.54145M -0.06553M -0.40133M -0.00637M
Change to liabilities - 0.38M -0.40314M 0.31M -0.21690M
Total cashflows from investing activities - -0.54145M -0.06553M -0.40133M -0.00637M
Net borrowings - -0.12207M -0.10310M -0.06999M -0.31284M
Total cash from financing activities 0.15M 35.38M 10.18M 6.05M 4.60M
Change to operating activities - - - - -
Net income -13.90560M -14.01600M -6.53452M -6.10334M -5.45466M
Change in cash -12.42067M 22.59M 4.32M 1.09M -0.08462M
Begin period cash flow 28.87M 6.28M 1.96M 0.88M 0.96M
End period cash flow 16.45M 28.87M 6.28M 1.96M 0.88M
Total cash from operating activities -12.25803M -12.25047M -5.79470M -4.56571M -4.67635M
Issuance of capital stock 0.27M 37.31M 10.73M 6.37M 5.09M
Depreciation 1.04M 0.93M 0.88M 0.75M 0.63M
Other cashflows from investing activities - - - - 0.00018M
Dividends paid - - - - -
Change to inventory -0.28461M -0.44889M -0.42309M 0.10M -0.00192M
Change to account receivables - -0.62290M 0.29M -0.01474M -0.06952M
Sale purchase of stock - - 10.20M 6.21M 5.09M
Other cashflows from financing activities -0.11967M -1.92373M -0.54477M -0.32061M -0.18284M
Change to netincome - 1.53M 0.39M 0.40M 0.44M
Capital expenditures 0.06M 0.54M 0.07M 0.40M 0.00655M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -0.83371M -0.69552M -0.53814M 0.39M -0.28834M
Stock based compensation 1.21M 1.81M 0.47M 0.31M 0.25M
Other non cash items 0.24M -0.28878M -0.08104M 0.09M 0.19M
Free cash flow -12.32198M -12.79192M -5.86023M -4.96704M -4.68290M

Peer Comparison

Sector: Healthcare Industry: Medical Devices

Company Change (GBX) Price (GBX) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
POLX
Polarean Imaging Plc
- -% - - - 36.05 1.40 17.76 -0.4544
SN
Smith & Nephew PLC
14.50 1.28% 1147.00 23.24 12.47 1.70 2.59 2.67 10.76
NIOX
NIOX Group PLC
-1.2 1.96% 60.00 28.20 18.73 4.84 3.41 4.35 13.85
EKF
EKF Diagnostics Holdings Plc
-0.2 0.75% 26.40 - 34.97 2.02 1.46 1.72 7.01
CREO
Creo Medical Group PLC
- -% 13.75 - - 199.36 0.74 6.21 8.16

Reports Covered

Stock Research & News

Profile

Polarean Imaging plc operates as a medical drug-device combination company serving the medical imaging market. The company engages in the research, development, and commercialization of novel imaging solutions with a non-invasive and radiation-free functional imaging platform. Its research equipment includes HPX hyperpolarizer, HPX measurement station, HPX gas manifold, chest coil, and dose delivery bags. Polarean Imaging plc was incorporated in 2016 and is based in Durham, North Carolina.

Polarean Imaging Plc

2500 Meridian Parkway, Durham, NC, United States, 27713

Key Executives

Name Title Year Born
Mr. Kenneth Paul West Chairman 1957
Mr. Clairis Richard Hullihen CEO & Director 1953
Dr. Bastiaan Driehuys Ph.D. Founder, CTO & Director 1969
Mr. Charles Fremont Osborne Jr. CFO & Director 1966
Mr. Neil Wadehra VP of Operations 1980
Mr. Alex Dusek Chief Commercial Officer 1967
Mr. Stephen Austin Company Sec. NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

We use cookies to help us improve, promote, and protect our services. By continuing to use this site, we assume you consent to our Cookies Policy. For more information, read our Privacy Policy and Terms and Conditions